Aberrant expression of STC1 had been observed in human carcinoma samples including colorectal cancer, breast cancer, lung adenocarcinoma, hepatocellular carcinoma, and thyroid carcinomas [35–37]. This evidence concerns the gene STC1 and breast carcinoma.